Suchergebnisse - "Lefèvre, Gilbert"

PubPharm (29)

1

A Pooled Analysis of Three Randomized Phase I/IIa Clinical Trials Confirms Absence of a Clinically Relevant Effect on the QTc Interval by Umibecestat

enthalten in: Clinical and translational science | 2020

von Vormfelde, S. | Pezous, N. | Lefèvre, G. | +5

2

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women : A pharmacokinetic-pharmacodynamic meta-analysis

enthalten in: PLoS medicine | 2018

von Kloprogge, F. | Workman, L. | Borrmann, S. | +37

3

Erratum to : Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data

enthalten in: BMC medicine | 2016

von WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group | Ashley, E. | Aweeka, F. | +42

ErratumFor: BMC Med. 2015 Sep 18;13:227. - PMID 26381375

4

Effects of Renal Impairment on Steady-State Plasma Concentrations of Rivastigmine : A Population Pharmacokinetic Analysis of Capsule and Patch Formulations in Patients with Alzheimer's Disease

enthalten in: Drugs & aging | 2016

von Lefèvre, G. | Callegari, F. | Gsteiger, S. | +1

5

Pharmacokinetic Modeling to Simulate the Concentration-Time Profiles After Dermal Application of Rivastigmine Patch

enthalten in: Journal of pharmaceutical sciences | 2016

von Nozaki, S. | Yamaguchi, M. | Lefèvre, G.

6

Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®)

enthalten in: Malaria journal | 2015

von Tiono, A. | Tinto, H. | Alao, M. | +10

7

Open-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (cipargamin) and piperaquine

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Stein, D. | Jain, J. | Kangas, M. | +4

8

A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel antimalarial Spiroindolone KAE609 (Cipargamin) to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers

enthalten in: Antimicrobial agents and chemotherapy | 2014

von Leong, F. | Li, R. | Jain, J. | +4

9

Spiroindolone KAE609 for falciparum and vivax malaria

enthalten in: The New England journal of medicine | 2014

von White, N. | Pukrittayakamee, S. | Phyo, A. | +10

CommentIn: N Engl J Med. 2014 Jul 31;371(5):474-5. - PMID 25075840

10

Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem) for bioequivalence in a randomized, open-label, two-period study

enthalten in: Malaria journal | 2013

von Lefèvre, G. | Bhad, P. | Jain, J. | +4